Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Mar;47(3):1112-4.
doi: 10.1128/AAC.47.3.1112-1114.2003.

Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae

C Betriu  1 , E Culebras, M Gómez, I Rodríguez-Avial, B A Sánchez, M C Agreda, J J Picazo
Affiliations

Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae

C Betriu et al. Antimicrob Agents Chemother. 2003 Mar.

Abstract

The rates of resistance to erythromycin and clindamycin among Streptococcus agalactiae strains isolated in our hospital increased from 4.2 and 0.8% in 1993 to 17.4 and 12.1%, respectively, in 2001. Erythromycin resistance was mainly due to the presence of an Erm(B) methylase, while the M phenotype was detected in 3.8% of the strains. Telithromycin was very active against erythromycin-resistant strains, irrespective of their mechanisms of macrolide resistance.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Frequency of resistance of S. agalactiae to erythromycin and clindamycin from 1992 to 2001.
See this image and copyright information in PMC

References

    1. Andrews, J. I., D. J. Diekema, S. K. Hunter, P. R. Rhomberg, M. A. Pfaller, R. N. Jones, and G. V. Doern. 2000. Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. Am. J. Obstet. Gynecol. 183:859-862. - PubMed
    1. Barry, A. L., P. C. Fuchs, and S. D. Brown. 2001. Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci. Eur. J. Clin. Microbiol. Infect. Dis. 20:494-497. - PubMed
    1. Betriu, C., M. Gómez, A. Sánchez, A. Cruceyra, J. Romero, and J. J. Picazo. 1994. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob. Agents Chemother. 38:2183-2186. - PMC - PubMed
    1. Centers for Disease Control and Prevention. 1996. Prevention of perinatal group B streptococcal disease: a public health perspective. Morb. Mortal. Wkly. Rep. 45:1-24. - PubMed
    1. Culebras, E., I. Rodríguez-Avial, C. Betriu, M. Redondo, and J. J. Picazo. 2002. Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae. Antimicrob. Agents Chemother. 46:1574-1576. - PMC - PubMed

Publication types

MeSH terms